Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Tesla
TSLA
|
+$875M |
| 2 |
Advanced Micro Devices
AMD
|
+$777M |
| 3 |
Home Depot
HD
|
+$564M |
| 4 |
Meta Platforms (Facebook)
META
|
+$505M |
| 5 |
Merck
MRK
|
+$403M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$445M |
| 3 |
Chevron
CVX
|
+$395M |
| 4 |
Micron Technology
MU
|
+$379M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| 1 | Healthcare | 18.68% |
| 2 | Technology | 14.97% |
| 3 | Consumer Discretionary | 11.35% |
| 4 | Consumer Staples | 10.73% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2926
908 Devices
MASS
$217M
| $741K | ﹤0.01% |
+39,000
| New | +$741K |
|
2927
Pliant Therapeutics
PLRX
$93.9M
| $740K | ﹤0.01% |
105,600
+75,293
| +248% | +$528K |
|
|
SY
2928
So-Young International
SY
$395M
| $738K | ﹤0.01% |
372,928
+58,928
| +19% | +$117K |
|
2929
Invesco Water Resources ETF
PHO
$2.22B
| $737K | ﹤0.01% |
13,900
+1,500
| +12% | +$79.5K |
|
2930
GitLab
GTLB
$8.39B
| $735K | ﹤0.01% |
13,500
+10,900
| +419% | +$593K |
|
2931
Abeona Therapeutics
ABEO
$294M
| $733K | ﹤0.01% |
93,033
+5,928
| +7% | +$46.7K |
|
2932
Black Diamond Therapeutics
BDTX
$182M
| $733K | ﹤0.01% |
264,491
-120,909
| -31% | -$335K |
|
2933
Praxis Precision Medicines
PRAX
$851M
| $733K | ﹤0.01% |
4,787
+3,914
| +448% | +$599K |
|
2934
Vanguard S&P Small-Cap 600 ETF
VIOO
$3.03B
| $733K | ﹤0.01% |
7,400
+3,600
| +95% | +$357K |
|
|
NAPA
2935
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $733K | ﹤0.01% |
40,300
+28,700
| +247% | +$522K |
|
2936
Mirum Pharmaceuticals
MIRM
$3.71B
| $731K | ﹤0.01% |
33,200
+4,800
| +17% | +$106K |
|
2937
Algoma Steel
ASTL
$480M
| $730K | ﹤0.01% |
+64,900
| New | +$730K |
|
2938
Blue Ridge Bankshares
BRBS
$387M
| $729K | ﹤0.01% |
48,050
+13,650
| +40% | +$207K |
|
|
FBRT
2939
Franklin BSP Realty Trust
FBRT
$940M
| $728K | ﹤0.01% |
+52,100
| New | +$728K |
|
2940
NeueHealth
NEUE
$60.6M
| $726K | ﹤0.01% |
4,703
-8,392
| -64% | -$1.3M |
|
|
ATSG
2941
DELISTED
Air Transport Services Group, Inc.
ATSG
| $726K | ﹤0.01% |
+21,700
| New | +$726K |
|
|
MNRL
2942
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $726K | ﹤0.01% |
+28,400
| New | +$726K |
|
|
CALB
2943
DELISTED
California BanCorp Common Stock
CALB
| $724K | ﹤0.01% |
31,484
-5,501
| -15% | -$127K |
|
2944
First Guaranty Bancshares
FGBI
$123M
| $723K | ﹤0.01% |
30,183
-15,200
| -33% | -$364K |
|
2945
NextCure
NXTC
$14.7M
| $723K | ﹤0.01% |
12,400
+3,267
| +36% | +$190K |
|
2946
Zevia
ZVIA
$178M
| $723K | ﹤0.01% |
158,297
+76,174
| +93% | +$348K |
|
2947
iShares Micro-Cap ETF
IWC
$962M
| $722K | ﹤0.01% |
+5,600
| New | +$722K |
|
2948
Oak Valley Bancorp
OVLY
$241M
| $722K | ﹤0.01% |
39,107
-3,466
| -8% | -$64K |
|
2949
Akebia Therapeutics
AKBA
$774M
| $720K | ﹤0.01% |
1,003,327
+380,300
| +61% | +$273K |
|
|
USX
2950
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $720K | ﹤0.01% |
+185,600
| New | +$720K |
|